Skip to main content Accessibility help
  • Print publication year: 2011
  • Online publication date: January 2012

Chapter 39 - Reversalof neuromuscular blockade

from Part 6 - IntravenousAnesthetics and Adjunct Drugs

Suggested readings

AlstonT. Hofmann, Schmofmann: atracurium undergoes Michael elimination. Anesthesiology 2001; 95:273.
BeecherHK, ToddDP. A study of the deaths associated with anesthesia and surgery: based on a study of 599, 548 anesthesias in ten institutions 1948-1952, inclusive. Ann Surg 1954; 140:2–35.
DebaeneB, PlaudB, DillyMP, DonatiF. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98:1024–1047.
ErikssonNW.Videoradiographical computerized manometry in assessment of pharyngeal function in partially paralyzed humans. Anesthesiology 1995; A886.
KatzRL.Clinical neuromuscular pharmacology of pancuronium. Anesthesiology 1971; 34:550–556.
MolinaAL, de BoerHD, KlimekM, et al. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by accidental high dose sugammadex. Br J Anaesth 2007; 98:624–627.
SparrHJ, VermeyenKM, BeaufortAM, et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology 2007; 106:935–943.
TramèrMR, Fuchs-BuderT.Omitting antagonism of neuromuscular block: effect on postoperative nausea and vomiting and risk of residual paralysis. A systematic review. Br J Anaesth 1999; 82:379–386.